Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.580
-0.070 (-4.24%)
At close: Mar 28, 2025, 4:00 PM
1.630
+0.050 (3.16%)
After-hours: Mar 28, 2025, 7:07 PM EST

Armata Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Armata Pharmaceuticals stock has a target of 7.00, which predicts an increase of 343.04% from the current stock price of 1.58.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $7.00 $7.00 $7.00
Change +343.04% +343.04% +343.04% +343.04%
* Price targets were last updated on Dec 19, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Armata Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +343.04% Dec 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +343.04% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +343.04% Nov 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +343.04% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +343.04% Jul 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
5.61M
from 5.17M
Increased by 8.43%
Revenue Next Year
n/a
from 5.61M
EPS This Year
-1.73
from -0.89
EPS Next Year
-0.84
from -1.73
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
823.00K4.47M5.51M4.53M5.17M5.61M-
Revenue Growth
-443.62%23.11%-17.77%14.24%8.43%-
EPS
-1.35-0.96-1.08-1.91-0.89-1.73-0.84
EPS Growth
-------
Forward PE
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 5.8M n/a
Avg 5.6M n/a
Low 5.4M n/a

Revenue Growth

Revenue Growth 20252026
High
11.6%
-
Avg
8.4%
-
Low
4.2%
-

EPS Forecast

EPS 20252026
High -1.79 -0.86
Avg -1.73 -0.84
Low -1.67 -0.80

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.